cyramza

Generic: ramucirumab

Labeler: eli lilly and company
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name cyramza
Generic Name ramucirumab
Labeler eli lilly and company
Dosage Form SOLUTION
Routes
INTRAVENOUS
Active Ingredients

ramucirumab 10 mg/mL

Manufacturer
Eli Lilly and Company

Identifiers & Regulatory

Product NDC 0002-7669
Product ID 0002-7669_8f4af9a3-1e45-4174-a2a7-31477f46901a
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA125477
Listing Expiration 2026-12-31
Marketing Start 2014-04-21

Pharmacologic Class

Established (EPC)
vascular endothelial growth factor receptor 2 antagonist [epc]
Mechanism of Action
vegfr2 inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00027669
Hyphenated Format 0002-7669

Supplemental Identifiers

RxCUI
1657775 1657777 1657780 1657781
UNII
D99YVK4L0X
NUI
N0000191009 N0000020032

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name cyramza (source: ndc)
Generic Name ramucirumab (source: ndc)
Application Number BLA125477 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 10 mg/mL
source: ndc
Packaging
  • 1 VIAL, SINGLE-DOSE in 1 CARTON (0002-7669-01) / 10 mL in 1 VIAL, SINGLE-DOSE
source: ndc

Packages (1)

0002-7669-01 1 VIAL, SINGLE-DOSE in 1 CARTON (0002-7669-01) / 10 mL in 1 VIAL, SINGLE-DOSE

Ingredients (1)

ramucirumab (10 mg/mL)

Linked Drug Pages (1)

CYRAMZA ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "8f4af9a3-1e45-4174-a2a7-31477f46901a", "openfda": {"nui": ["N0000191009", "N0000020032"], "unii": ["D99YVK4L0X"], "rxcui": ["1657775", "1657777", "1657780", "1657781"], "spl_set_id": ["c6080942-dee6-423e-b688-1272c2ae90d4"], "pharm_class_epc": ["Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC]"], "pharm_class_moa": ["VEGFR2 Inhibitors [MoA]"], "manufacturer_name": ["Eli Lilly and Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (0002-7669-01)  / 10 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "0002-7669-01", "marketing_start_date": "20140421"}], "brand_name": "CYRAMZA", "product_id": "0002-7669_8f4af9a3-1e45-4174-a2a7-31477f46901a", "dosage_form": "SOLUTION", "pharm_class": ["VEGFR2 Inhibitors [MoA]", "Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC]"], "product_ndc": "0002-7669", "generic_name": "ramucirumab", "labeler_name": "Eli Lilly and Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "CYRAMZA", "active_ingredients": [{"name": "RAMUCIRUMAB", "strength": "10 mg/mL"}], "application_number": "BLA125477", "marketing_category": "BLA", "marketing_start_date": "20140421", "listing_expiration_date": "20261231"}